Industry Research Reports
Home > Reports > Consumer Goods > Global Dog Pharmaceuticals and Supplements Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Dog Pharmaceuticals and Supplements Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Consumer Goods
Published Date: 2025-10-03
Pages: 158 Pages
Report ld: 5149737
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Dog Pharmaceuticals and Supplements market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Veterinary pet supplements and nutraceuticals are widely used by dog, cat and horse owners across the United States, generating millions of dollars in revenue for manufacturers. Despite the widespread use of these veterinary products, oversight and regulation remain limited as compared to human dietary supplement regulations. This review describes the current regulation, quality control, safety and efficacy of pet supplements and nutraceuticals targeted towards the dog, cat and horse.
From a downstream perspective, Puppy accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Dog Pharmaceuticals and Supplements leading manufacturers including Virbac, Zoetis, Vetoquinol, Nestle Purina, NOW Foods, Nutramax Laboratories, Bayer, Foodscience corporation, Manna Pro Products, Ark Naturals, etc., dominate supply; the top five capture approximately % of global revenue, with Virbac leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Dog Pharmaceuticals and Supplements market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Virbac
- Zoetis
- Vetoquinol
- Nestle Purina
- NOW Foods
- Nutramax Laboratories
- Bayer
- Foodscience corporation
- Manna Pro Products
- Ark Naturals
- Blackmores
- Zesty Paws
- Nuvetlabs
- Mavlab
- Vetafarm
- Nupro Supplements
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Pharmaceuticals
- Supplements
Segment by Application
- Puppy
- Adult Dogs
CHAPTER OUTLINE
Chapter 1: Defines the Dog Pharmaceuticals and Supplements study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Dog Pharmaceuticals and Supplements: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Dog Pharmaceuticals and Supplements Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Pharmaceuticals
1.2.3 Supplements
1.3 Market Segmentation by Application
1.3.1 Global Dog Pharmaceuticals and Supplements Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Puppy
1.3.3 Adult Dogs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Dog Pharmaceuticals and Supplements Revenue Estimates and Forecasts 2020-2031
2.2 Global Dog Pharmaceuticals and Supplements Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Dog Pharmaceuticals and Supplements Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Dog Pharmaceuticals and Supplements Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Pharmaceuticals Market Size by Players
3.3.2 Supplements Market Size by Players
3.4 Global Dog Pharmaceuticals and Supplements Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Dog Pharmaceuticals and Supplements Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Dog Pharmaceuticals and Supplements Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Dog Pharmaceuticals and Supplements Market Size by Type (2020-2031)
6.4 North America Dog Pharmaceuticals and Supplements Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Dog Pharmaceuticals and Supplements Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Dog Pharmaceuticals and Supplements Market Size by Type (2020-2031)
7.4 Europe Dog Pharmaceuticals and Supplements Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Dog Pharmaceuticals and Supplements Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Dog Pharmaceuticals and Supplements Market Size by Type (2020-2031)
8.4 Asia-Pacific Dog Pharmaceuticals and Supplements Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Dog Pharmaceuticals and Supplements Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Dog Pharmaceuticals and Supplements Market Size by Type (2020-2031)
9.4 Central and South America Dog Pharmaceuticals and Supplements Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Dog Pharmaceuticals and Supplements Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Dog Pharmaceuticals and Supplements Market Size by Type (2020-2031)
10.4 Middle East and Africa Dog Pharmaceuticals and Supplements Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Dog Pharmaceuticals and Supplements Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Virbac
11.1.1 Virbac Corporation Information
11.1.2 Virbac Business Overview
11.1.3 Virbac Dog Pharmaceuticals and Supplements Product Features and Attributes
11.1.4 Virbac Dog Pharmaceuticals and Supplements Revenue and Gross Margin (2020-2025)
11.1.5 Virbac Dog Pharmaceuticals and Supplements Revenue by Product in 2024
11.1.6 Virbac Dog Pharmaceuticals and Supplements Revenue by Application in 2024
11.1.7 Virbac Dog Pharmaceuticals and Supplements Revenue by Geographic Area in 2024
11.1.8 Virbac Dog Pharmaceuticals and Supplements SWOT Analysis
11.1.9 Virbac Recent Developments
11.2 Zoetis
11.2.1 Zoetis Corporation Information
11.2.2 Zoetis Business Overview
11.2.3 Zoetis Dog Pharmaceuticals and Supplements Product Features and Attributes
11.2.4 Zoetis Dog Pharmaceuticals and Supplements Revenue and Gross Margin (2020-2025)
11.2.5 Zoetis Dog Pharmaceuticals and Supplements Revenue by Product in 2024
11.2.6 Zoetis Dog Pharmaceuticals and Supplements Revenue by Application in 2024
11.2.7 Zoetis Dog Pharmaceuticals and Supplements Revenue by Geographic Area in 2024
11.2.8 Zoetis Dog Pharmaceuticals and Supplements SWOT Analysis
11.2.9 Zoetis Recent Developments
11.3 Vetoquinol
11.3.1 Vetoquinol Corporation Information
11.3.2 Vetoquinol Business Overview
11.3.3 Vetoquinol Dog Pharmaceuticals and Supplements Product Features and Attributes
11.3.4 Vetoquinol Dog Pharmaceuticals and Supplements Revenue and Gross Margin (2020-2025)
11.3.5 Vetoquinol Dog Pharmaceuticals and Supplements Revenue by Product in 2024
11.3.6 Vetoquinol Dog Pharmaceuticals and Supplements Revenue by Application in 2024
11.3.7 Vetoquinol Dog Pharmaceuticals and Supplements Revenue by Geographic Area in 2024
11.3.8 Vetoquinol Dog Pharmaceuticals and Supplements SWOT Analysis
11.3.9 Vetoquinol Recent Developments
11.4 Nestle Purina
11.4.1 Nestle Purina Corporation Information
11.4.2 Nestle Purina Business Overview
11.4.3 Nestle Purina Dog Pharmaceuticals and Supplements Product Features and Attributes
11.4.4 Nestle Purina Dog Pharmaceuticals and Supplements Revenue and Gross Margin (2020-2025)
11.4.5 Nestle Purina Dog Pharmaceuticals and Supplements Revenue by Product in 2024
11.4.6 Nestle Purina Dog Pharmaceuticals and Supplements Revenue by Application in 2024
11.4.7 Nestle Purina Dog Pharmaceuticals and Supplements Revenue by Geographic Area in 2024
11.4.8 Nestle Purina Dog Pharmaceuticals and Supplements SWOT Analysis
11.4.9 Nestle Purina Recent Developments
11.5 NOW Foods
11.5.1 NOW Foods Corporation Information
11.5.2 NOW Foods Business Overview
11.5.3 NOW Foods Dog Pharmaceuticals and Supplements Product Features and Attributes
11.5.4 NOW Foods Dog Pharmaceuticals and Supplements Revenue and Gross Margin (2020-2025)
11.5.5 NOW Foods Dog Pharmaceuticals and Supplements Revenue by Product in 2024
11.5.6 NOW Foods Dog Pharmaceuticals and Supplements Revenue by Application in 2024
11.5.7 NOW Foods Dog Pharmaceuticals and Supplements Revenue by Geographic Area in 2024
11.5.8 NOW Foods Dog Pharmaceuticals and Supplements SWOT Analysis
11.5.9 NOW Foods Recent Developments
11.6 Nutramax Laboratories
11.6.1 Nutramax Laboratories Corporation Information
11.6.2 Nutramax Laboratories Business Overview
11.6.3 Nutramax Laboratories Dog Pharmaceuticals and Supplements Product Features and Attributes
11.6.4 Nutramax Laboratories Dog Pharmaceuticals and Supplements Revenue and Gross Margin (2020-2025)
11.6.5 Nutramax Laboratories Recent Developments
11.7 Bayer
11.7.1 Bayer Corporation Information
11.7.2 Bayer Business Overview
11.7.3 Bayer Dog Pharmaceuticals and Supplements Product Features and Attributes
11.7.4 Bayer Dog Pharmaceuticals and Supplements Revenue and Gross Margin (2020-2025)
11.7.5 Bayer Recent Developments
11.8 Foodscience corporation
11.8.1 Foodscience corporation Corporation Information
11.8.2 Foodscience corporation Business Overview
11.8.3 Foodscience corporation Dog Pharmaceuticals and Supplements Product Features and Attributes
11.8.4 Foodscience corporation Dog Pharmaceuticals and Supplements Revenue and Gross Margin (2020-2025)
11.8.5 Foodscience corporation Recent Developments
11.9 Manna Pro Products
11.9.1 Manna Pro Products Corporation Information
11.9.2 Manna Pro Products Business Overview
11.9.3 Manna Pro Products Dog Pharmaceuticals and Supplements Product Features and Attributes
11.9.4 Manna Pro Products Dog Pharmaceuticals and Supplements Revenue and Gross Margin (2020-2025)
11.9.5 Manna Pro Products Recent Developments
11.10 Ark Naturals
11.10.1 Ark Naturals Corporation Information
11.10.2 Ark Naturals Business Overview
11.10.3 Ark Naturals Dog Pharmaceuticals and Supplements Product Features and Attributes
11.10.4 Ark Naturals Dog Pharmaceuticals and Supplements Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Blackmores
11.11.1 Blackmores Corporation Information
11.11.2 Blackmores Business Overview
11.11.3 Blackmores Dog Pharmaceuticals and Supplements Product Features and Attributes
11.11.4 Blackmores Dog Pharmaceuticals and Supplements Revenue and Gross Margin (2020-2025)
11.11.5 Blackmores Recent Developments
11.12 Zesty Paws
11.12.1 Zesty Paws Corporation Information
11.12.2 Zesty Paws Business Overview
11.12.3 Zesty Paws Dog Pharmaceuticals and Supplements Product Features and Attributes
11.12.4 Zesty Paws Dog Pharmaceuticals and Supplements Revenue and Gross Margin (2020-2025)
11.12.5 Zesty Paws Recent Developments
11.13 Nuvetlabs
11.13.1 Nuvetlabs Corporation Information
11.13.2 Nuvetlabs Business Overview
11.13.3 Nuvetlabs Dog Pharmaceuticals and Supplements Product Features and Attributes
11.13.4 Nuvetlabs Dog Pharmaceuticals and Supplements Revenue and Gross Margin (2020-2025)
11.13.5 Nuvetlabs Recent Developments
11.14 Mavlab
11.14.1 Mavlab Corporation Information
11.14.2 Mavlab Business Overview
11.14.3 Mavlab Dog Pharmaceuticals and Supplements Product Features and Attributes
11.14.4 Mavlab Dog Pharmaceuticals and Supplements Revenue and Gross Margin (2020-2025)
11.14.5 Mavlab Recent Developments
11.15 Vetafarm
11.15.1 Vetafarm Corporation Information
11.15.2 Vetafarm Business Overview
11.15.3 Vetafarm Dog Pharmaceuticals and Supplements Product Features and Attributes
11.15.4 Vetafarm Dog Pharmaceuticals and Supplements Revenue and Gross Margin (2020-2025)
11.15.5 Vetafarm Recent Developments
11.16 Nupro Supplements
11.16.1 Nupro Supplements Corporation Information
11.16.2 Nupro Supplements Business Overview
11.16.3 Nupro Supplements Dog Pharmaceuticals and Supplements Product Features and Attributes
11.16.4 Nupro Supplements Dog Pharmaceuticals and Supplements Revenue and Gross Margin (2020-2025)
11.16.5 Nupro Supplements Recent Developments
12 Dog Pharmaceuticals and SupplementsIndustry Chain Analysis
12.1 Dog Pharmaceuticals and Supplements Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Dog Pharmaceuticals and Supplements Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Dog Pharmaceuticals and Supplements Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Dog Pharmaceuticals and Supplements Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Dog Pharmaceuticals and Supplements Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Dog Pharmaceuticals and Supplements Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Dog Pharmaceuticals and Supplements Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Dog Pharmaceuticals and Supplements Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Dog Pharmaceuticals and Supplements Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Dog Pharmaceuticals and Supplements Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Dog Pharmaceuticals and Supplements by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dog Pharmaceuticals and Supplements as of 2024)
Table 11. Global Dog Pharmaceuticals and Supplements Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Dog Pharmaceuticals and Supplements Companies Headquarters
Table 13. Global Dog Pharmaceuticals and Supplements Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Dog Pharmaceuticals and Supplements Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Dog Pharmaceuticals and Supplements Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Dog Pharmaceuticals and Supplements Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Dog Pharmaceuticals and Supplements Revenue by Application (2026-2031) & (US$ Million)
Table 21. Dog Pharmaceuticals and Supplements High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Dog Pharmaceuticals and Supplements Growth Accelerators and Market Barriers
Table 25. North America Dog Pharmaceuticals and Supplements Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Dog Pharmaceuticals and Supplements Growth Accelerators and Market Barriers
Table 27. Europe Dog Pharmaceuticals and Supplements Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Dog Pharmaceuticals and Supplements Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Dog Pharmaceuticals and Supplements Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Dog Pharmaceuticals and Supplements Investment Opportunities and Key Challenges
Table 31. Central and South America Dog Pharmaceuticals and Supplements Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Dog Pharmaceuticals and Supplements Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Dog Pharmaceuticals and Supplements Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Virbac Corporation Information
Table 35. Virbac Description and Major Businesses
Table 36. Virbac Product Features and Attributes
Table 37. Virbac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Virbac Revenue Proportion by Product in 2024
Table 39. Virbac Revenue Proportion by Application in 2024
Table 40. Virbac Revenue Proportion by Geographic Area in 2024
Table 41. Virbac Dog Pharmaceuticals and Supplements SWOT Analysis
Table 42. Virbac Recent Developments
Table 43. Zoetis Corporation Information
Table 44. Zoetis Description and Major Businesses
Table 45. Zoetis Product Features and Attributes
Table 46. Zoetis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Zoetis Revenue Proportion by Product in 2024
Table 48. Zoetis Revenue Proportion by Application in 2024
Table 49. Zoetis Revenue Proportion by Geographic Area in 2024
Table 50. Zoetis Dog Pharmaceuticals and Supplements SWOT Analysis
Table 51. Zoetis Recent Developments
Table 52. Vetoquinol Corporation Information
Table 53. Vetoquinol Description and Major Businesses
Table 54. Vetoquinol Product Features and Attributes
Table 55. Vetoquinol Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Vetoquinol Revenue Proportion by Product in 2024
Table 57. Vetoquinol Revenue Proportion by Application in 2024
Table 58. Vetoquinol Revenue Proportion by Geographic Area in 2024
Table 59. Vetoquinol Dog Pharmaceuticals and Supplements SWOT Analysis
Table 60. Vetoquinol Recent Developments
Table 61. Nestle Purina Corporation Information
Table 62. Nestle Purina Description and Major Businesses
Table 63. Nestle Purina Product Features and Attributes
Table 64. Nestle Purina Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Nestle Purina Revenue Proportion by Product in 2024
Table 66. Nestle Purina Revenue Proportion by Application in 2024
Table 67. Nestle Purina Revenue Proportion by Geographic Area in 2024
Table 68. Nestle Purina Dog Pharmaceuticals and Supplements SWOT Analysis
Table 69. Nestle Purina Recent Developments
Table 70. NOW Foods Corporation Information
Table 71. NOW Foods Description and Major Businesses
Table 72. NOW Foods Product Features and Attributes
Table 73. NOW Foods Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. NOW Foods Revenue Proportion by Product in 2024
Table 75. NOW Foods Revenue Proportion by Application in 2024
Table 76. NOW Foods Revenue Proportion by Geographic Area in 2024
Table 77. NOW Foods Dog Pharmaceuticals and Supplements SWOT Analysis
Table 78. NOW Foods Recent Developments
Table 79. Nutramax Laboratories Corporation Information
Table 80. Nutramax Laboratories Description and Major Businesses
Table 81. Nutramax Laboratories Product Features and Attributes
Table 82. Nutramax Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Nutramax Laboratories Recent Developments
Table 84. Bayer Corporation Information
Table 85. Bayer Description and Major Businesses
Table 86. Bayer Product Features and Attributes
Table 87. Bayer Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Bayer Recent Developments
Table 89. Foodscience corporation Corporation Information
Table 90. Foodscience corporation Description and Major Businesses
Table 91. Foodscience corporation Product Features and Attributes
Table 92. Foodscience corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Foodscience corporation Recent Developments
Table 94. Manna Pro Products Corporation Information
Table 95. Manna Pro Products Description and Major Businesses
Table 96. Manna Pro Products Product Features and Attributes
Table 97. Manna Pro Products Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Manna Pro Products Recent Developments
Table 99. Ark Naturals Corporation Information
Table 100. Ark Naturals Description and Major Businesses
Table 101. Ark Naturals Product Features and Attributes
Table 102. Ark Naturals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Ark Naturals Recent Developments
Table 104. Blackmores Corporation Information
Table 105. Blackmores Description and Major Businesses
Table 106. Blackmores Product Features and Attributes
Table 107. Blackmores Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Blackmores Recent Developments
Table 109. Zesty Paws Corporation Information
Table 110. Zesty Paws Description and Major Businesses
Table 111. Zesty Paws Product Features and Attributes
Table 112. Zesty Paws Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Zesty Paws Recent Developments
Table 114. Nuvetlabs Corporation Information
Table 115. Nuvetlabs Description and Major Businesses
Table 116. Nuvetlabs Product Features and Attributes
Table 117. Nuvetlabs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Nuvetlabs Recent Developments
Table 119. Mavlab Corporation Information
Table 120. Mavlab Description and Major Businesses
Table 121. Mavlab Product Features and Attributes
Table 122. Mavlab Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Mavlab Recent Developments
Table 124. Vetafarm Corporation Information
Table 125. Vetafarm Description and Major Businesses
Table 126. Vetafarm Product Features and Attributes
Table 127. Vetafarm Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Vetafarm Recent Developments
Table 129. Nupro Supplements Corporation Information
Table 130. Nupro Supplements Description and Major Businesses
Table 131. Nupro Supplements Product Features and Attributes
Table 132. Nupro Supplements Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Nupro Supplements Recent Developments
Table 134. Raw Materials Key Suppliers
Table 135. Distributors List
Table 136. Market Trends and Market Evolution
Table 137. Market Drivers and Opportunities
Table 138. Market Challenges, Risks, and Restraints
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Dog Pharmaceuticals and Supplements Product Picture
Figure 2. Global Dog Pharmaceuticals and Supplements Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Pharmaceuticals Product Picture
Figure 4. Supplements Product Picture
Figure 5. Global Dog Pharmaceuticals and Supplements Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Puppy
Figure 7. Adult Dogs
Figure 8. Dog Pharmaceuticals and Supplements Report Years Considered
Figure 9. Global Dog Pharmaceuticals and Supplements Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Dog Pharmaceuticals and Supplements Revenue (2020-2031) & (US$ Million)
Figure 11. Global Dog Pharmaceuticals and Supplements Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Dog Pharmaceuticals and Supplements Revenue Market Share by Region (2020-2031)
Figure 13. Global Dog Pharmaceuticals and Supplements Revenue Market Share Ranking (2024)
Figure 14. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 15. Pharmaceuticals Revenue Market Share by Player in 2024
Figure 16. Supplements Revenue Market Share by Player in 2024
Figure 17. Global Dog Pharmaceuticals and Supplements Revenue Market Share by Type (2020-2031)
Figure 18. Global Dog Pharmaceuticals and Supplements Revenue Market Share by Application (2020-2031)
Figure 19. North America Dog Pharmaceuticals and Supplements Revenue YoY (2020-2031) & (US$ Million)
Figure 20. North America Top 5 Players Dog Pharmaceuticals and Supplements Revenue (US$ Million) in 2024
Figure 21. North America Dog Pharmaceuticals and Supplements Revenue (US$ Million) by Type (2020 - 2031)
Figure 22. North America Dog Pharmaceuticals and Supplements Revenue (US$ Million) by Application (2020-2031)
Figure 23. US Dog Pharmaceuticals and Supplements Revenue (2020-2031) & (US$ Million)
Figure 24. Canada Dog Pharmaceuticals and Supplements Revenue (2020-2031) & (US$ Million)
Figure 25. Mexico Dog Pharmaceuticals and Supplements Revenue (2020-2031) & (US$ Million)
Figure 26. Europe Dog Pharmaceuticals and Supplements Revenue YoY (2020-2031) & (US$ Million)
Figure 27. Europe Top 5 Players Dog Pharmaceuticals and Supplements Revenue (US$ Million) in 2024
Figure 28. Europe Dog Pharmaceuticals and Supplements Revenue (US$ Million) by Type (2020-2031)
Figure 29. Europe Dog Pharmaceuticals and Supplements Revenue (US$ Million) by Application (2020-2031)
Figure 30. Germany Dog Pharmaceuticals and Supplements Revenue (2020-2031) & (US$ Million)
Figure 31. France Dog Pharmaceuticals and Supplements Revenue (2020-2031) & (US$ Million)
Figure 32. U.K. Dog Pharmaceuticals and Supplements Revenue (2020-2031) & (US$ Million)
Figure 33. Italy Dog Pharmaceuticals and Supplements Revenue (2020-2031) & (US$ Million)
Figure 34. Russia Dog Pharmaceuticals and Supplements Revenue (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Dog Pharmaceuticals and Supplements Revenue YoY (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Top 8 Players Dog Pharmaceuticals and Supplements Revenue (US$ Million) in 2024
Figure 37. Asia-Pacific Dog Pharmaceuticals and Supplements Revenue (US$ Million) by Type (2020-2031)
Figure 38. Asia-Pacific Dog Pharmaceuticals and Supplements Revenue (US$ Million) by Application (2020-2031)
Figure 39. Indonesia Dog Pharmaceuticals and Supplements Revenue (2020-2031) & (US$ Million)
Figure 40. Japan Dog Pharmaceuticals and Supplements Revenue (2020-2031) & (US$ Million)
Figure 41. South Korea Dog Pharmaceuticals and Supplements Revenue (2020-2031) & (US$ Million)
Figure 42. Australia Dog Pharmaceuticals and Supplements Revenue (2020-2031) & (US$ Million)
Figure 43. India Dog Pharmaceuticals and Supplements Revenue (2020-2031) & (US$ Million)
Figure 44. Indonesia Dog Pharmaceuticals and Supplements Revenue (2020-2031) & (US$ Million)
Figure 45. Vietnam Dog Pharmaceuticals and Supplements Revenue (2020-2031) & (US$ Million)
Figure 46. Malaysia Dog Pharmaceuticals and Supplements Revenue (2020-2031) & (US$ Million)
Figure 47. Philippines Dog Pharmaceuticals and Supplements Revenue (2020-2031) & (US$ Million)
Figure 48. Singapore Dog Pharmaceuticals and Supplements Revenue (2020-2031) & (US$ Million)
Figure 49. Central and South America Dog Pharmaceuticals and Supplements Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Central and South America Top 5 Players Dog Pharmaceuticals and Supplements Revenue (US$ Million) in 2024
Figure 51. Central and South America Dog Pharmaceuticals and Supplements Revenue (US$ Million) by Type (2020-2031)
Figure 52. Central and South America Dog Pharmaceuticals and Supplements Revenue (US$ Million) by Application (2020-2031)
Figure 53. Brazil Dog Pharmaceuticals and Supplements Revenue (2020-2025) & (US$ Million)
Figure 54. Argentina Dog Pharmaceuticals and Supplements Revenue (2020-2025) & (US$ Million)
Figure 55. Middle East and Africa Dog Pharmaceuticals and Supplements Revenue YoY (2020-2031) & (US$ Million)
Figure 56. Middle East and Africa Top 5 Players Dog Pharmaceuticals and Supplements Revenue (US$ Million) in 2024
Figure 57. South America Dog Pharmaceuticals and Supplements Revenue (US$ Million) by Type (2020-2031)
Figure 58. Middle East and Africa Dog Pharmaceuticals and Supplements Revenue (US$ Million) by Application (2020-2031)
Figure 59. GCC Countries Dog Pharmaceuticals and Supplements Revenue (2020-2025) & (US$ Million)
Figure 60. Israel Dog Pharmaceuticals and Supplements Revenue (2020-2025) & (US$ Million)
Figure 61. Egypt Dog Pharmaceuticals and Supplements Revenue (2020-2025) & (US$ Million)
Figure 62. South Africa Dog Pharmaceuticals and Supplements Revenue (2020-2025) & (US$ Million)
Figure 63. Dog Pharmaceuticals and Supplements Industry Chain Mapping
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Dog Pharmaceuticals and Supplements market?
The top companies in the global Dog Pharmaceuticals and Supplements market are Virbac、Zoetis、Vetoquinol.
Related Reports
Dog Pharmaceuticals and Supplements - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Dog Pharmaceuticals and Supplements was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-02-11
Pages: 122
USD 3950.00
(Single User License)
Global Dog Pharmaceuticals and Supplements Market Research Report 2026
The global Dog Pharmaceuticals and Supplements market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-02-11
Pages: 129
USD 2900.00
(Single User License)
Global Dog Pharmaceuticals and Supplements Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Dog Pharmaceuticals and Supplements market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 104
USD 4250.00
(Single User License)
Dog Pharmaceuticals and Supplements- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Dog Pharmaceuticals and Supplements was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-02
Pages: 123
USD 3950.00
(Single User License)
Global Dog Pharmaceuticals and Supplements Market Research Report 2025
The global market for Dog Pharmaceuticals and Supplements was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-02
Pages: 97
USD 2900.00
(Single User License)
Global Dog Pharmaceuticals and Supplements Market Insights, Forecast to 2030
Veterinary pet supplements and nutraceuticals are widely used by dog, cat and horse owners across the United States, generating millions of dollars in revenue for manufacturers. Despite the widespread use of these veterinary products, oversight and regulation remain limited as compared to human dietary supplement regulations. This review describes the current regulation, quality control, safety and efficacy of pet supplements and nutraceuticals targeted towards the dog, cat and horse.
Published Date: 2024-04-26
Pages: 112
USD 4900.00
(Single User License)
Dog Pharmaceuticals and Supplements - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Dog Pharmaceuticals and Supplements was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 122
USD 3950.00 (Single User License)Global Dog Pharmaceuticals and Supplements Market Research Report 2026
The global Dog Pharmaceuticals and Supplements market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 129
USD 2900.00 (Single User License)Global Dog Pharmaceuticals and Supplements Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Dog Pharmaceuticals and Supplements market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 104
USD 4250.00 (Single User License)Dog Pharmaceuticals and Supplements- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Dog Pharmaceuticals and Supplements was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-02
Pages: 123
USD 3950.00 (Single User License)Global Dog Pharmaceuticals and Supplements Market Research Report 2025
The global market for Dog Pharmaceuticals and Supplements was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-02
Pages: 97
USD 2900.00 (Single User License)Global Dog Pharmaceuticals and Supplements Market Insights, Forecast to 2030
Veterinary pet supplements and nutraceuticals are widely used by dog, cat and horse owners across the United States, generating millions of dollars in revenue for manufacturers. Despite the widespread use of these veterinary products, oversight and regulation remain limited as compared to human dietary supplement regulations. This review describes the current regulation, quality control, safety and efficacy of pet supplements and nutraceuticals targeted towards the dog, cat and horse.
Published: 2024-04-26
Pages: 112
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now